MARIETTA, Ga., July 9, 2013 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that the Company will visit the NASDAQ MarketSite in Times Square and ring the Opening Bell on Friday, July 12, 2013.
Parker H. "Pete" Petit, Chairman and CEO will perform the honorary ringing of the Opening Bell. Bill Taylor, President and COO; Mike Senken, Chief Financial Officer; Debbie Dean, Executive Vice President; Brent Miller, Executive Vice President; Thornton Kuntz, Vice President Human Resources & Administration; and Mike Carlton, Vice President Global Sales, will be joining Mr. Petit in the ceremony.
"Our listing on NASDAQ represents another significant milestone in our strategy to broaden our exposure to the investment community and to increase the trading volume in our stock," said Petit. "Joining the NASDAQ Exchange also comes at an important time for MiMedx as the Company has just become part of the Russell 2000."
The Opening Bell will ring at 9:30 am Eastern Daylight Time and will be televised on CNBC or can be viewed online at www.nasdaq.com.
About the Company
MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroF
|SOURCE MiMedx Group, Inc.|
Copyright©2012 PR Newswire.
All rights reserved